ArticleInfection and drug resistance2011
Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis.
Article in Infection and drug resistance, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 66 citations in OpenAlex.
- Comparison of clinical and microbiological features between mucoid and non-mucoidMicrobiology spectrum · 2026Article
- Aerosolized antibiotics therapy for infected traumatic pulmonary pseudocysts: A case report.Trauma case reports · 2023Article
- Eupatorin and Salviandulin-A, with Antimicrobial and Anti-Inflammatory Effects fromPlants (Basel, Switzerland) · 2022Article
- EF-hand protein, EfhP, specifically binds CaScientific reports · 2022Article
- Structure-Based Design of α-Substituted Mercaptoacetamides as Inhibitors of the Virulence Factor LasB fromACS infectious diseases · 2022Article
- Substrate-Inspired Fragment Merging and Growing Affords Efficacious LasB Inhibitors.Angewandte Chemie (International ed. in English) · 2022Article
- Review
- Quantitative proteomic reveals gallium maltolate induces an iron-limited stress response and reduced quorum-sensing in Pseudomonas aeruginosa.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2020Article
- Antimicrobial Properties of the Polyaniline Composites againstJournal of functional biomaterials · 2020Article
- Article
- TheMolecular & cellular proteomics : MCP · 2020Article
- Minimum Bactericidal Concentration of Ciprofloxacin toSensors and actuators. B, Chemical · 2020Article
- Characterization of Putative Virulence Factors ofBioMed research international · 2020Article
- Bacterial Type I CRISPR-Cas systems influence inflammasome activation in mammalian host by promoting autophagy.Immunology · 2019Article
- Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens.International journal of molecular sciences · 2019Review
- Pyoverdine-Dependent Virulence ofFrontiers in microbiology · 2019Article
- Targeting theBeilstein journal of organic chemistry · 2018Review
- Article
- In vivo therapeutic efficacy of frog skin-derived peptides against Pseudomonas aeruginosa-induced pulmonary infection.Scientific reports · 2017Article
- Distribution ofJournal of preventive medicine and hygiene · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cystic fibrosis (CF) is the most common life-limiting inherited disease in Caucasian populations. The main cause of death in CF patients is respiratory failure resulting from chronic pulmonary infection. Pseudomonas aeruginosa is the most prevalent organism in the airway colonization of CF patients, and its persistence in the airways has been related to greater morbidity with a more rapid deterioration in lung function. P. aeruginosa has enormous genetic and metabolic flexibility that allows it to adapt and persist within the airways of CF patients, and it has the ability to easily acquire antimicrobial resistance. For these reasons, the management of infections and chronic colonization by P. aeruginosa remains a challenge for physicians. This article reviews the current and future antibacterial chemotherapy options for respiratory pseudomonal infection in CF patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.